Skip to content

Clinical trials

Dyslipidemias trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: India Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
200610
20082
20091
20101
20113
20121
20133
20171
20181
20192
20211
20233
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Unknown status5
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
Kowa Research Europe4
All India Institute of Medical Sciences2
Amarin Pharma Inc.2
Novartis Pharmaceuticals2
Zydus Lifesciences Limited2
89bio, Inc.1
All India Institute of Medical Sciences, Bhubaneswar1
Amgen1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias33
Diabetes Mellitus, Type 211
Diabetes Mellitus8
Glucose Metabolism Disorders8
Hypercholesterolemia6
Hyperlipidemias5
Hypertension5
Hypertriglyceridemia5
Insulin Resistance4
Metabolic Syndrome4

Trials

Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.